Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Trial of Budesonide Turbuhaler vs Placebo in High-Risk Individuals with Indeterminate Lung Nodules
2005-004614-32Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lung nodule (SPN) and bronchial carcinoma comparing Budesonide arm with Placebo arm (2 arms). Primary endpoint: Intermediate biomarker modulation in lung carcinogenesis. Started Jun 2006; status: completed.
02
Drugs
budesonide
03
Conditions
lung nodule (SPN)bronchial carcinoma
Beyond the preview
Go deeper on 2005-004614-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004614-32.